Clinical trial
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT00170170 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00170170 |
|---|---|
| Title | Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation |
| Official title | Clinical Predictors of Late-onset CMV Disease in Solid Organ Transplant Recipients: A Strategy to Improve the Benefits and Reduce the Risks of Anti-CMV Prophylaxis |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Transplantation, Infection, Cytomegalovirus Infections |
| Enrollment | 500 |
| Start date | Nov 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Feb 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: